Search results

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 18 November 2020

Angioedema has been added as a potential adverse effect of treatment (frequency – rare).

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 16 November 2020

To discontinue treatment in patients with Parkinson's disease, ropinirole should be tapered off, as patients with impulse control disorders and those receiving high daily dose and/or cumulative doses...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 16 November 2020

SPCs updated to include Kaposi’s sarcoma (a rare type of cancer caused by a virus, which can affect the skin and mouth and potentially the internal organs) as an adverse effect of treatment of...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 24 November 2020

SPC revised with licence extension to include use in combination with nivolumab and 2 cycles of platinum-based chemotherapy for the first-line treatment of metastatic non-small cell lung cancer in...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 23 November 2020

SPC revised with licence extension to include use in combination with ipilimumab and 2 cycles of platinum-based chemotherapy for the first-line treatment of metastatic non-small cell lung cancer in...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 23 November 2020

SPC warns galantamine can cause bradycardia (common) and all types of atrioventricular node block (rare); and galantamine bioavailability increases during co-administration of paroxetine (CYP2D6...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 23 November 2020

SPC updated to include rash as a very rare (<1/10,000) immune system disorder related reaction to treatment with choriogonadotropin alfa in the treatment of anovulatory or oligo-ovulatory adult women.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 23 November 2020

SPCs updated to include extension of licence, to include treatment of patients with cystic fibrosis, aged at least 4 months, weighing 5 kg to less than 25 kg, with revisions in various sections to...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 20 November 2020

SPC updated to include details for the licence extension adjunctive use in children aged 4 years, and for partial-onset seizures and from 7 years for idiopathic generalised epilepsy.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 20 November 2020

SPC now states that Cerazette can be used during breastfeeding although infrequent post marketing reports suggest a decrease in milk production.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)